#MBRX Moleculin Biotech to Participate in Advances in Oncology Panel at the 2026 Maxim Growth Summit

https://www.stocktitan.net/news/MBRX/moleculin-biotech-to-participate-in-advances-in-oncology-panel-at-gq7msnf8s1s0.html?utm_source=stocktitan-bluesky&utm_medium=social

#MBRX Moleculin Announces Publication of Peer-Reviewed Cardiac Safety Analysis of Annamycin in Frontiers in Cardiovascular Medicine

https://www.stocktitan.net/news/MBRX/moleculin-announces-publication-of-peer-reviewed-cardiac-safety-ua8g4hxcsvtj.html?utm_source=stocktitan-bluesky&utm_medium=social

#MBRX Annamycin Turns “Cold” Pancreatic Tumors “Hot” in New Preclinical Data Presented at AACR

https://www.stocktitan.net/news/MBRX/annamycin-turns-cold-pancreatic-tumors-hot-in-new-preclinical-data-us7aq8516g51.html?utm_source=stocktitan-bluesky&utm_medium=social

#MBRX Moleculin Biotech Secures Mexican Patent Protecting Lung-Targeted Liposomal Annamycin Through 2040

https://www.stocktitan.net/news/MBRX/moleculin-biotech-secures-mexican-patent-protecting-lung-targeted-yxqa7k1khsf4.html?utm_source=stocktitan-bluesky&utm_medium=social

🚨 JUST IN: $MBRX
Moleculin Biotech receives Nasdaq delisting notice; bid price below $1 for 30 days

#SEC #stocks #investing #MBRX #Regulatory
🔗 secwatch.observer

#MBRX Moleculin to Showcase New Annamycin Data at AACR Conference on Pancreatic Cancer and Two European Scientific Meetings

https://www.stocktitan.net/news/MBRX/moleculin-to-showcase-new-annamycin-data-at-aacr-conference-on-8t12m9gifbvi.html?utm_source=stocktitan-bluesky&utm_medium=social

#MBRX Moleculin Presentation from H.C. Wainwright Conference Now Available On-Demand

https://www.stocktitan.net/news/MBRX/moleculin-presentation-from-h-c-wainwright-conference-now-available-xmmwzn7ntium.html?utm_source=stocktitan-bluesky&utm_medium=social